Rathlev T, Franks G F
Am J Clin Pathol. 1982 Jun;77(6):705-9. doi: 10.1093/ajcp/77.6.705.
Enzyme glucose oxidase was used as the label on the secondary antibody in an indirect ANA-test procedure using rat kidney tissue as the antigen-source. Glucose oxidase is not endogenously present in mammalian tissues and, therefore, produces no background staining as obtained with flurochrome and peroxidase labels, which are commonly used to detect tissue antigens. Pseudoperoxidase-like activity of the haptoglobin-hemoglobin complexes in mammalian tissues is responsible for the interfering background stain when peroxidase label is used. Unlike Diaminobenzidine, the staining reagent commonly used with peroxidase, chromogenic reagents used with glucose oxidase are not carcinogenic. Glucose oxidase as a label for antibodies has advantages over flurochrome labels in being permanently stable, producing no background stain, and increasing the sensitivity of the method. Comparative evaluation of the glucose oxidase procedure and the commonly used flurochrome-ANA and peroxidase-ANA methods is reported. Results with 150 serum samples show the potential of this new method as a routine ANA-testing procedure in clinical laboratories.
在以大鼠肾脏组织为抗原源的间接抗核抗体(ANA)检测程序中,葡萄糖氧化酶用作二抗上的标记物。葡萄糖氧化酶并非内源性存在于哺乳动物组织中,因此,不会像通常用于检测组织抗原的荧光染料和过氧化物酶标记那样产生背景染色。当使用过氧化物酶标记时,哺乳动物组织中触珠蛋白 - 血红蛋白复合物的假过氧化物酶样活性会导致干扰性背景染色。与通常与过氧化物酶一起使用的二氨基联苯胺不同,与葡萄糖氧化酶一起使用的显色试剂不具有致癌性。葡萄糖氧化酶作为抗体标记物,相对于荧光染料标记具有永久性稳定、不产生背景染色以及提高方法灵敏度等优势。本文报道了葡萄糖氧化酶检测程序与常用的荧光染料 - ANA和过氧化物酶 - ANA方法的比较评估。对150份血清样本的检测结果表明了这种新方法作为临床实验室常规ANA检测程序的潜力。